Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 1 to 17 of 17

TitleReference numberPublishedLast updated
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)TA702
Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal)TA703
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapiesTA704
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplantHTG580
Transvaginal laser therapy for stress urinary incontinenceHTG581
Transvaginal laser therapy for urogenital atrophyHTG582
Electrohydraulic lithotripsy for difficult-to-treat bile duct stonesHTG583
Heavy menstrual bleeding: assessment and managementNG88
Crisaborole for treating mild to moderate atopic dermatitis in people 2 years and older (terminated appraisal)TA701
Ravulizumab for treating paroxysmal nocturnal haemoglobinuriaTA698
Ofatumumab for treating relapsing multiple sclerosisTA699
Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcersHTG355
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiographyHTG429
KODEX-EPD for cardiac imaging during ablation of arrhythmiasMIB260
Permanent His-bundle pacemaker implantation for treating heart failureHTG579
Axonics sacral neuromodulation system for faecal incontinenceMIB259
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasiaHTG578

Results per page

  1. 10
  2. 25
  3. 50
  4. All